These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36450478)

  • 1. Impairments to executive function in emerging adults with Huntington disease.
    Pfalzer AC; Watson KH; Ciriegio AE; Hale L; Diehl S; McDonell KE; Vnencak-Jones C; Huitz E; Snow A; Roth MC; Guthrie CS; Riordan H; Long JD; Compas BE; Claassen DO
    J Neurol Neurosurg Psychiatry; 2023 Feb; 94(2):130-135. PubMed ID: 36450478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
    Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
    J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
    Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
    Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition, function and awareness of disease impact in early Parkinson's and Huntington's disease.
    Júlio F; Ribeiro MJ; Morgadinho A; Sousa M; van Asselen M; Simões MR; Castelo-Branco M; Januário C
    Disabil Rehabil; 2022 Mar; 44(6):921-939. PubMed ID: 32620060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the association between apathy and deficits of social cognition and executive functions in Huntington's disease.
    Hendel RK; Hellem MNN; Hjermind LE; Nielsen JE; Vogel A
    J Int Neuropsychol Soc; 2023 May; 29(4):369-376. PubMed ID: 36189712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD.
    Long JD; Paulsen JS;
    Mov Disord; 2015 Oct; 30(12):1664-72. PubMed ID: 26340420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.
    Nithianantharajah J; Hannan AJ
    Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive signs in prodromal Huntington disease.
    Stout JC; Paulsen JS; Queller S; Solomon AC; Whitlock KB; Campbell JC; Carlozzi N; Duff K; Beglinger LJ; Langbehn DR; Johnson SA; Biglan KM; Aylward EH
    Neuropsychology; 2011 Jan; 25(1):1-14. PubMed ID: 20919768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
    ; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A; Hersch S; Penney J; Marder K; Paulsen J; Quaid K; Siemers E; Tanner C; Mallonee W; Suter G; Dubinsky R; Gray C; Nance M; Bundlie S; Radtke D; Kostyk S; Baic C; Caress J; Walker F; Hunt V; O'Neill C; Chouinard S; Factor S; Greenamyre T; Wood-Siverio C; Corey-Bloom J; Song D; Peavy G; Moskowitz C; Wesson M; Samii A; Bird T; Lipe H; Blindauer K; Marshall F; Zimmerman C; Goldstein J; Rosas D; Novak P; Caviness J; Adler C; Duffy A; Wheelock V; Tempkin T; Richman D; Seeberger L; Albin R; Chou KL; Racette B; Perlmutter JS; Perlman S; Bordelon Y; Martin W; Wieler M; Leavitt B; Raymond L; Decolongon J; Clarke L; Jankovic J; Hunter C; Hauser RA; Sanchez-Ramos J; Furtado S; Suchowersky O; Klimek ML; Guttman M; Sethna R; Feigin A; Cox M; Shannon B; Percy A; Dure L; Harrison M; Johnson W; Higgins D; Molho E; Nickerson C; Evans S; Hobson D; Singer C; Galvez-Jimenez N; Shannon K; Comella C; Ross C; Saint-Hilaire MH; Testa C; Rosenblatt A; Hogarth P; Weiner W; Como P; Kumar R; Cotto C; Stout J; Brocht A; Watts A; Eberly S; Weaver C; Foroud T; Gusella J; MacDonald M; Myers R; Fahn S; Shults C
    JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
    Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
    Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-Motor Phenotype Relates to Neuropsychiatric and Cognitive Disorders in Huntington's Disease.
    Julayanont P; Heilman KM; McFarland NR
    Mov Disord; 2020 May; 35(5):781-788. PubMed ID: 31922295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive decline in Huntington's disease expansion gene carriers.
    Baake V; Reijntjes RHAM; Dumas EM; Thompson JC; ; Roos RAC
    Cortex; 2017 Oct; 95():51-62. PubMed ID: 28843844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive deficits predict poorer functional capacity in Huntington's disease: but what is being measured?
    Eddy CM; Rickards HE
    Neuropsychology; 2015 Mar; 29(2):268-73. PubMed ID: 25110931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.
    Hahn-Barma V; Deweer B; Dürr A; Dodé C; Feingold J; Pillon B; Agid Y; Brice A; Dubois B
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):172-7. PubMed ID: 9489526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor onset and diagnosis in Huntington disease using the diagnostic confidence level.
    Liu D; Long JD; Zhang Y; Raymond LA; Marder K; Rosser A; McCusker EA; Mills JA; Paulsen JS;
    J Neurol; 2015 Dec; 262(12):2691-8. PubMed ID: 26410751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive domains that predict time to diagnosis in prodromal Huntington disease.
    Harrington DL; Smith MM; Zhang Y; Carlozzi NE; Paulsen JS;
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):612-9. PubMed ID: 22451099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease.
    Di Tella S; Lo Monaco MR; Petracca M; Zinzi P; Solito M; Piano C; Calabresi P; Silveri MC; Bentivoglio AR
    J Neurol; 2022 Dec; 269(12):6634-6640. PubMed ID: 35915275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations of intermediate allele carriers in Huntington disease.
    Cubo E; Ramos-Arroyo MA; Martinez-Horta S; Martínez-Descalls A; Calvo S; Gil-Polo C;
    Neurology; 2016 Aug; 87(6):571-8. PubMed ID: 27402890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence.
    Julayanont P; McFarland NR; Heilman KM
    J Neurol Sci; 2020 Jan; 408():116523. PubMed ID: 31678902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.